Covid Archives - Office-account

GENEVA (Reuters) – Greenhouse gas concentrations climbed to a new record in 2019 and rose again this year despite an expected drop in emissions due to COVID-19 lockdowns, the World Meteorological Organization said on Monday, warning against complacency.

Many scientists expect the biggest annual fall in carbon emissions in generations this year as measures to contain coronavirus have grounded planes, docked ships and kept commuters at home.

However, the WMO described the projected 2020 drop as a “tiny blip” and said the resulting impact on the carbon dioxide concentrations that contribute to global warming would be no bigger than normal annual fluctuations.

“…In the short-term the impact of the COVID-19 confinements cannot be distinguished from natural variability,” the WMO’s Greenhouse Gas Bulletin said.

The annual report released by the Geneva-based U.N. agency measures the atmospheric concentration of the gases – carbon dioxide, methane and nitrous oxide – that are warming

future technology

Vaccine mRNA research from Moderna, Pfizer vs COVID huge for science

[email protected]_84 November 23, 2020

Pfizer and Moderna have both announced promising results in the phase 3 trials of their COVID-19 vaccines. Here’s how they differ.

Storyful

The success of two COVID-19 candidate vaccines marks a turning point in the long history of vaccines and could lead to major advances against a variety of diseases.

Vaccines developed by Pfizer/BioNTech and Moderna are more than 95% effective against COVID-19, trials show. Both depend on a technology never before used in a commercial vaccine that could upend the way future ones are made.

This new messenger RNA technology, as well another method that depends on viruses to deliver vaccines, are transforming the field, said Brendan Wren, a professor of vaccinology at the London School of Hygiene and Tropical Medicine.

“It could be quite a new era for vaccines and vaccinology,” he said. “We seemed to move ahead in this one year 10 years.”

These technologies had

technology

The Technology 202: Four reasons why covid exposure apps haven’t taken off in the United States yet

[email protected]_84 November 23, 2020

But these apps are most effective when more people join them — and to date, the United States has had a scattered rollout of the technology. But there is early research abroad indicating that the technology can play a role in limiting the spread of the virus.

Here are four reasons that coronavirus exposure apps haven’t taken off yet here:

1. There’s a patchwork of different systems in the United States.

The federal government hasn’t rolled out a single exposure notification system for the whole country, so Americans instead have to rely on a patchwork of different state and local apps. As of Nov. 20, 15 U.S. states and territories, plus D.C., supported coronavirus exposure alerts. Geoffrey made a helpful guide allowing you to check if it’s available in your state, and turn on the notifications.

Several large states have also announced their intent to launch exposure notification technology or

future technology

Four reasons why covid exposure apps haven’t taken off in the United States yet

[email protected]_84 November 23, 2020

with Tonya Riley

Coronavirus cases are climbing throughout the country. But the vast majority of Americans have yet to install contact-tracing apps, which can alert them if they’ve been near someone who has tested positive for the virus.

graphical user interface, text, application, chat or text message: Covidwise is a free download, as seen here, on the Google Play app store. it's also available on Apple's iPhone app store. (Photo by Jonathan Baran/The Washington Post)

© Jonathan Baran/TWP
Covidwise is a free download, as seen here, on the Google Play app store. it’s also available on Apple’s iPhone app store. (Photo by Jonathan Baran/The Washington Post)

About 100 million people now have access to what’s known as “exposure notification” technology, which can send a pop-up notification after people spent time near a person who later tested positive for the coronavirus, my colleague Geoffrey A. Fowler reports. The alerts – which are built using software created by Apple and Google – were widely seen as one of Silicon Valley’s most critical roles in the coronavirus response.

But these apps are most effective when more people join them

new technology

China’s Xi Jinping is pushing for a global Covid QR code. He may struggle to convince the world

[email protected]_84 November 23, 2020

Chinese President Xi Jinping is pushing for a global Covid-19 tracking system using QR codes, to help fast-track international travel and business during the coronavirus pandemic.

Xi Jinping wearing a suit and tie: Chinese President Xi Jinping delivers a speech via video link to the Leaders' Side Event on Safeguarding the Planet at the G20 Riyadh Summit on November 20.

© Li Xueren/Xinhua News Agency/Getty Images
Chinese President Xi Jinping delivers a speech via video link to the Leaders’ Side Event on Safeguarding the Planet at the G20 Riyadh Summit on November 20.

China mandated the widespread use of QR-based health certificates earlier this year. The system, which uses an electronic barcode to store a person’s travel and health history, has been credited with helping to curb the spread of the virus.

The code issues users with a color code based on their potential exposure to the novel coronavirus. The colors are like traffic lights — green is safest, then amber and finally red.

Speaking at the virtual G20 leaders’ meeting on Saturday, Xi said that to ensure the “smooth functioning” of the

technology articles

Israel and the U.S. among the best places to be a woman entrepreneur as Covid shakes up ranking

[email protected]_84 November 23, 2020

Israel has charged past the United States and Switzerland to rank as the world’s best place to be a woman entrepreneur, according to a new report released Monday.

a person sitting at a desk in front of a computer

© Provided by CNBC

The Middle Eastern nation jumped up three places this year to steal the title from New Zealand after Covid-19 caused a shakeup in the annual Mastercard Index of Women Entrepreneurs (MIWE).

Load Error

The four frontrunners were joined in the top 10 for the first time by Poland, Sweden and Spain, which rose rapidly this year to form a geographically varied leading list. The United Kingdom, Canada and Australia rounded out the top 10 as high-income economies fared better for female founders under the pandemic.

Now in its fourth year, MIWE examines the working environments of 58 economies — representing almost 80% of the world’s female labor force — to measure their success in fostering

science in the news

Should I Fly During COVID? Scientists Answer: Probably.

[email protected]_84 November 22, 2020

BuzzFeed News; Getty Images

As the coronavirus surges out of control throughout the United States, many Americans are wondering whether it’s safe to fly home for the holidays.

Unfortunately, science has no easy answers.

Research shows that the virus can float indoors in tiny particles and infect those nearby. The good news: Studies suggest that the chances of inhaling these aerosols and catching COVID-19 on a plane are low, thanks in large part to powerful ventilation systems and strict mask-wearing requirements.

But the risk is not zero. And some of these studies assume conditions that don’t necessarily exist in the real world, like that everyone will wear their mask during the whole flight. A chunk of this research was also financially supported by the airline industry — which has a vested interest in portraying flying as safe after a year of gutting financial losses. Some researchers told BuzzFeed News that

science

Near-Term Catalysts to Watch for COVID Vaccine Stocks

[email protected]_84 November 21, 2020

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have reported great efficacy results for their coronavirus vaccine candidate BNT162b2. Moderna (NASDAQ:MRNA) announced outstanding efficacy results for its experimental vaccine mRNA-1273. What are the next near-term catalysts for investors to look for? Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights answer that question in this Motley Fool Live video recorded on Nov. 16, 2020.

Corinne Cardina: So what are some near-term catalysts that investors should be keeping an eye on? What kind of articles are you planning in the next week is what I should be asking, because I know you’re keeping an eye on everything.

Keith Speights: Yeah. Near-term catalysts, the obvious ones are emergency use authorization filings by Pfizer and by Moderna. Pfizer’s should come this week. Either this week, I would say at least by next week. But they were saying third week of November, and if

latest technology

Covid vaccine technology pioneer: ‘I never doubted it would work’ | Medical research

[email protected]_84 November 21, 2020

The Hungarian-born biochemist who helped pioneer the research behind the mRNA technology used in the two Covid-19 vaccines showing positive results believes it was always a no-brainer.

“I never doubted it would work,” Katalin Karikó told the Guardian. “I had seen the data from animal studies, and I was expecting it. I always wished that I would live long enough to see something that I’ve worked on be approved.”

This month has been the pinnacle of Karikó’s lifelong work researching mRNA, or messenger ribonucleic acid.

The 65-year-old, who left Hungary in 1985 to pursue an academic career in the US with her husband, toddler and just £900 hidden in a teddy bear, has now been suggested as a possible Nobel prize winner.

Her work helped pave the way for both the Pfizer/BioNTech and the Moderna coronavirus vaccines. Both have shown efficacy of about 95% in late-stage clinical trials. They are

technology

Small Covid Test Maker Is Going Viral

[email protected]_84 November 20, 2020

(Award-winning tech columnist Jon Markman publishes of Strategic Advantage, a popular daily newsletter about the digital transformation of business, entertainment and society — and how to invest in it. Click here for a free two-week trial.)

COVID-19 is surging throughout the country, creating an opportunity for agile diagnostic businesses. This is how one newcomer is building an empire.

Elon Musk made news last week when the Tesla ((TSLA) -Get Report) founder claimed to test both positive and negative for the novel coronavirus, twice. Forty five weeks into the global pandemic and the United States still has a testing problem.

Fulgent Genetics ((FLGT) -Get Report), a smaller company with a $908 million market cap that most investors don’t know, has a solution.

The problem, apart from the raging infection rates globally, is that not all tests are created equally.

Some, like the four given to Musk,

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Flash News

NPL and Cambridge Quantum Computing (CQC) collaborate in quantum computing

India FinTech Forum Selects 27 Fintech Startups for IFTA 2020

On-premises data warehouses are dead

More efforts needed for forest protection: expert

Moto E7 announced with an incredibly low price and big camera promises

Trust The Science, But Celebrate The Business Of Covid-19 Vaccines

TOP 6 Beauty Trends of 2020 — Revel in the most celebrated trends and product innovations unveiled in CosmoTrends

Don’t Wait for Black Friday to Shop

How Archaeologists Are Using Deep Learning to Dig Deeper

UK telecom companies face big fines under new security law

Tag: Covid

Surge in Greenhouse Gases Sustained Despite COVID Lockdowns: U.N. | World News

Vaccine mRNA research from Moderna, Pfizer vs COVID huge for science

The Technology 202: Four reasons why covid exposure apps haven’t taken off in the United States yet

1. There’s a patchwork of different systems in the United States.

Four reasons why covid exposure apps haven’t taken off in the United States yet

China’s Xi Jinping is pushing for a global Covid QR code. He may struggle to convince the world

Israel and the U.S. among the best places to be a woman entrepreneur as Covid shakes up ranking

Should I Fly During COVID? Scientists Answer: Probably.

Near-Term Catalysts to Watch for COVID Vaccine Stocks

Covid vaccine technology pioneer: ‘I never doubted it would work’ | Medical research

Small Covid Test Maker Is Going Viral